M33 (oral ) fin, min and dermastamp 9/25/2026
Similar Community Posts Join
5 / 5 resultscommunity 3 months and one week on Oral Fin and Oral Min Scalp update.. no matter how far gone you guys are it‘s not too late.
A 22-year-old experienced significant hair regrowth using 1.25mg finasteride daily, 5mg oral minoxidil daily, ketoconazole shampoo, dermastamping, and scalp massages. The user reported moving from Norwood 6 to Norwood 1.5 in less than three months, with the strongest regrowth between months 2 and 3.
community Fin + Min & Derma stamp for 1 year. Don't really notice much difference?
The user has been using finasteride, minoxidil, and a derma stamp for a year with minimal noticeable hair regrowth, but others suggest there is slight improvement and recommend continuing the treatment. Some users suggest switching to dutasteride or adjusting the derma stamp technique for better results.
community My 5 year hair loss journey on Min & Fin.
A user shared their 5-year experience using minoxidil and finasteride, noting significant hair improvements without side effects. Consistency, a positive mindset, and lifestyle changes like a healthier diet and better sleep were key to their success.
community 2020 & now today. I'm disappointed to my results
The user is disappointed with their hair loss treatment results using Minoxidil, dermastamping, and ketoconazole shampoo. They are advised to add Finasteride or Dutasteride to block DHT for better results.
community I post relatively a lot here. I knew I could help more people like me. Because I learned a lot from here. I actually met good people here, from afar, who helped me grow my hair. As you can see, I was almost bald at age 34, and today I am 35.5 with very good hair. Oral Propecia, topical Minoxidil..
A user shared their successful hair regrowth journey using oral Propecia, topical Minoxidil, Ketozol shampoo, a derma roller, strength training, Omega 3, and Biotin. They experienced initial shedding but saw significant improvement in hair growth after 3-4 months.
Related Research
6 / 6 resultsresearch Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
This review discusses the pharmacological actions and potential therapeutic benefits of ginsenoside compound K for metabolic disorders, reports no new clinical results, and suggests further research on its bioavailability and toxicity.
research Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
This study observed that oral tofacitinib was reasonably well-tolerated but had limited efficacy in treating alopecia areata, with a clinical response seen in 41.4% of patients over six months.
research Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C’s of oral therapy
This study found that 78% of patients continued taking oral minoxidil for androgenetic or traction alopecia, with 33% reporting decreased hair shedding and 28% noting increased scalp hair.
research Flavonoids in safflower extract reduce cisplatin-induced damage to human follicle dermal papilla cells by inhibiting DNA damage and Rad17/Chk1/Cdc25C signaling
The study found that safflower extract may help protect human follicle dermal papilla cells from cisplatin-induced damage, suggesting its potential as an adjuvant in chemotherapy to mitigate hair follicle cell damage.
research The effect of spironolactone on genital skin 5α-reductase activity
This study found that spironolactone directly inhibits 5 alpha-reductase activity in hirsute women, resulting in decreased conversion of testosterone to dihydrotestosterone, which may contribute to its therapeutic effects.
research Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
This study found that mild-to-moderate COVID-19 was not associated with worsening in patients with pre-existing alopecia areata.